-+ 0.00%
-+ 0.00%
-+ 0.00%

Oruka Therapeutics General Counsel Paul Quinlan disposes of USD 931,699.56 in common shares

PUBT·09/21/2026 20:57:48
Listen to the news
Oruka Therapeutics General Counsel Paul Quinlan disposes of USD 931,699.56 in common shares
  • Oruka Therapeutics General Counsel Paul T Quinlan exercised an employee warrant to buy 10,000 common shares at $7.8 on Sept. 21, 2026.
  • Quinlan sold 10,000 common shares the same day at weighted-average prices ranging from $92.37 to $95.31.
  • He ended the day with 29,995 common shares beneficially owned.
  • Quinlan also reported 79,996 employee warrants outstanding following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000100), on September 21, 2026, and is solely responsible for the information contained therein.